Open-label, multicenter study on the safety, tolerability, and efficacy of Simulect in pediatric renal transplant recipients receiving triple therapy with cyclosporin, mycophenolate, and corticosteroids. [electronic resource]
Producer: 20050926Description: 672-4 p. digitalISSN:- 0041-1345
- Adrenal Cortex Hormones -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Basiliximab
- Biopsy
- Cadaver
- Child
- Cyclosporine -- therapeutic use
- Drug Therapy, Combination
- Female
- Graft Rejection -- pathology
- Histocompatibility Testing
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kidney Transplantation -- immunology
- Living Donors
- Male
- Mycophenolic Acid -- therapeutic use
- Prospective Studies
- Recombinant Fusion Proteins -- therapeutic use
- Safety
- Tissue Donors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.